Lobbying

Trinetx's latest lobbying report covers Q4 2019, at $30K. Its first report covers Q4 2019; the issues it reports most are Health Issues.

Trinetx

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2019
The first quarter a report named it

Lobbying by quarter

Trinetx lobbying by quarter
Trinetx lobbying by quarter
QuarterAmountReports
Q4 2019$30K1
Q1 2020$00
Q2 2020$00
Q3 2020$00
Q4 2020$00
Q1 2021$00
Q2 2021$00
Q3 2021$00
Q4 2021$00
Q1 2022$00
Q2 2022$00
Q3 2022$00
Q4 2022$00
Q1 2023$00
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$30K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Disease Control & Prevention (CDC)1 reports
  • Food & Drug Administration (FDA)1 reports
  • HOUSE OF REPRESENTATIVES1 reports
  • Natl Institutes of Health (NIH)1 reports
  • SENATE1 reports

Firms it paid

Firm
Venn Strategies$30K1 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/02for Q4 2019Venn Strategies$30K